Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01496131 · ClinicalTrials.gov registry record · Phase 2
Tecemotide (L-BLP25) in Prostate Cancer
A Phase 2 study, sponsored by EMD Serono.
- Completed
- Registry status
- Phase 2
- Development phase
- 28
- Enrollment target
NCT01496131 is a Phase 2 study that has completed, run by EMD Serono. The registered enrollment target is 28 participants.
The verdict
NCT01496131, a Phase 2 study, has completed, sponsored by EMD Serono.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 28 participants
- Enrollment target
Study Summary
This study examines tecemotide (L-BLP25) in combination with standard treatment for prostate cancer.
Interventions
- DRUG Cyclophosphamide
- DRUG Goserelin
- RADIATION Radiation therapy
- DRUG Tecemotide (L-BLP25)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2011-10-24 |
| Est. Completion | 2016-11-25 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01496131
The ClinicalTrials.gov registry entry for NCT01496131 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is EMD Serono, which has 71 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Cyclophosphamide is the first listed.
NCT01496131 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01496131 about?
NCT01496131 is a clinical study titled "Tecemotide (L-BLP25) in Prostate Cancer". This study examines tecemotide (L-BLP25) in combination with standard treatment for prostate cancer.
What is the current status of trial NCT01496131?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 28 participants. The study started on 2011-10-24. Estimated completion is 2016-11-25.
What interventions are being tested in trial NCT01496131?
The interventions under investigation include: Cyclophosphamide (DRUG), Goserelin (DRUG), Radiation therapy (RADIATION), Tecemotide (L-BLP25) (DRUG).
Who is sponsoring clinical trial NCT01496131?
This trial is sponsored by EMD Serono, which has 71 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.